Courses

Previously given courses:

25-28/03/2008
Molecular Genetic Epidemiology in the Postgenomic Era.
Date and location: 25-28 March 2008, Tampere, Finland.
Poster
Program

Doctoral Program in Public Health, with emphasis on biobank-based research
>> CCPRB - SoE Announcement

26-28/08/2006
Nordic Research Seminar on Biobanking Seminar date and location: 26-28 August 2006, Malmö, Sweden.
>> Announcement, final program
>> Lectures given at the course

18-21/04/2006
Genetic epidemiology in the postgenomic era
course date and location: 18-21 April 2006, Tampere, Finland.
>> More information about this course

Contractors involved

The present network has linked large biobank projects with up to 30 years of follow-up and >60.000 prospectively occurring cancer cases and cancer registries with >40 years of population-based registration. The project is coordinated by Professor Joakim Dillner at Lund University, Dept. of Medical Microbiology at the University Hospital in Malmö, Sweden. There are 18 partners in the project from 9 European countries, including e.g. 7 cancer registries, 20 biobank projects and a number of platforms for advanced technologic analysis of biobank samples.

Description of project objectives

1. Provide the study base for uniquely large population-based prospective studies on cancer
    
2. Define and implement a generally applicable European Quality Standard for Biobanking that will include improved data and specimen standardisation, acquisition and analysis, reliable and standardised statistical analysis as well as improved management and co-ordination of European biobanks.
    
3. Define and promote the implementation of integrity-proof methods for biobank-based research involving well defined and secure third party code-keeping systems.
    
4. Enable large-scale, population-based research on:
   
   
   
   1. evaluation of cancer treatment and role of molecular markers in treatment selection
   
   
   
   2. use over-generation registry linkages applied to large biobank cohorts to identify and evaluate genetic predisposition associated with increased cancer risk as well as interactions with common environmental exposures.
   
   
   
   3. use over-generation registry linkages applied to large biobank cohorts to explore and evaluate intrauterine exposures associated with increased cancer risk
   
   
   
   4. exploit the power of large population cohorts for design of optimal strategies for cancer prevention and its evaluation.
       
5. Establish a Europe-wide network for spreading the awareness of i) the data, samples and knowledge generated European biobank-based research ii) possibilities for future biobank-based research and iii) the best practise quality standards for biobank-based research.